GLP-1 weight loss drugs may soon be coming for first graders, with new research from the makers of Ozempic and Wegovy finding that kids between 6 and 11 lost significant weight on the drug, which protects them from serious obesity-related health problems down the line.

But parents may want to think twice about seeking a prescription for junior: In addition to weight loss, they found that semaglutide use in young kids also produced a troubling side effect.

Novo Nordisk’s new research found that kids on semaglutide (sold as Wegovy) lost weight but also grew over an inch less than kids who were not on the drug.

Doctors say it’s unclear how this…

Read the full article at NYPOST.COM